Metcela presented at American Heart Association (AHA) Scientific Sessions 2021 | Metcela Inc.

Metcela’s Co-founder/Co-CEO, Takahiro (Taka) Iwamiya presented ePoster at this year’s AHA Scientific Sessions.

Abstract: P2496

“Heterogeneity and Plasticity of Cardiac Fibroblasts Governing Reparative Lymphangiogenesis After Myocardial Infarction: A New Therapeutic Approach for Heart Failure”


For further information, please go to their website ⇒ AHA website